Global Bevacizumab Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Bevacizumab, sold under the trade name Avastin, is a medication used to treat a number of types of cancers and a specific eye disease.
LPI (LP Information)' newest research report, the “Bevacizumab Industry Forecast” looks at past sales and reviews total world Bevacizumab sales in 2022, providing a comprehensive analysis by region and market sector of projected Bevacizumab sales for 2023 through 2029. With Bevacizumab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bevacizumab industry.
This Insight Report provides a comprehensive analysis of the global Bevacizumab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bevacizumab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Bevacizumab market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bevacizumab and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bevacizumab.
The global Bevacizumab market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Bevacizumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Bevacizumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Bevacizumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Bevacizumab players cover Genentech and Amgen etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Bevacizumab market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Bevacizumab market?
What factors are driving Bevacizumab market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bevacizumab market opportunities vary by end market size?
How does Bevacizumab break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Bevacizumab, sold under the trade name Avastin, is a medication used to treat a number of types of cancers and a specific eye disease.
LPI (LP Information)' newest research report, the “Bevacizumab Industry Forecast” looks at past sales and reviews total world Bevacizumab sales in 2022, providing a comprehensive analysis by region and market sector of projected Bevacizumab sales for 2023 through 2029. With Bevacizumab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bevacizumab industry.
This Insight Report provides a comprehensive analysis of the global Bevacizumab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bevacizumab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Bevacizumab market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bevacizumab and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bevacizumab.
The global Bevacizumab market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Bevacizumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Bevacizumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Bevacizumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Bevacizumab players cover Genentech and Amgen etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Bevacizumab market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Avastin (bevacizumab)
- Mvasi (bevacizumab-awwb)
- Cancer
- Eye Diease
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Genentech
- Amgen
What is the 10-year outlook for the global Bevacizumab market?
What factors are driving Bevacizumab market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bevacizumab market opportunities vary by end market size?
How does Bevacizumab break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Bevacizumab Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Bevacizumab by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Bevacizumab by Country/Region, 2018, 2022 & 2029
2.2 Bevacizumab Segment by Type
2.2.1 Avastin (bevacizumab)
2.2.2 Mvasi (bevacizumab-awwb)
2.3 Bevacizumab Sales by Type
2.3.1 Global Bevacizumab Sales Market Share by Type (2018-2023)
2.3.2 Global Bevacizumab Revenue and Market Share by Type (2018-2023)
2.3.3 Global Bevacizumab Sale Price by Type (2018-2023)
2.4 Bevacizumab Segment by Application
2.4.1 Cancer
2.4.2 Eye Diease
2.5 Bevacizumab Sales by Application
2.5.1 Global Bevacizumab Sale Market Share by Application (2018-2023)
2.5.2 Global Bevacizumab Revenue and Market Share by Application (2018-2023)
2.5.3 Global Bevacizumab Sale Price by Application (2018-2023)
3 GLOBAL BEVACIZUMAB BY COMPANY
3.1 Global Bevacizumab Breakdown Data by Company
3.1.1 Global Bevacizumab Annual Sales by Company (2018-2023)
3.1.2 Global Bevacizumab Sales Market Share by Company (2018-2023)
3.2 Global Bevacizumab Annual Revenue by Company (2018-2023)
3.2.1 Global Bevacizumab Revenue by Company (2018-2023)
3.2.2 Global Bevacizumab Revenue Market Share by Company (2018-2023)
3.3 Global Bevacizumab Sale Price by Company
3.4 Key Manufacturers Bevacizumab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bevacizumab Product Location Distribution
3.4.2 Players Bevacizumab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BEVACIZUMAB BY GEOGRAPHIC REGION
4.1 World Historic Bevacizumab Market Size by Geographic Region (2018-2023)
4.1.1 Global Bevacizumab Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Bevacizumab Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Bevacizumab Market Size by Country/Region (2018-2023)
4.2.1 Global Bevacizumab Annual Sales by Country/Region (2018-2023)
4.2.2 Global Bevacizumab Annual Revenue by Country/Region (2018-2023)
4.3 Americas Bevacizumab Sales Growth
4.4 APAC Bevacizumab Sales Growth
4.5 Europe Bevacizumab Sales Growth
4.6 Middle East & Africa Bevacizumab Sales Growth
5 AMERICAS
5.1 Americas Bevacizumab Sales by Country
5.1.1 Americas Bevacizumab Sales by Country (2018-2023)
5.1.2 Americas Bevacizumab Revenue by Country (2018-2023)
5.2 Americas Bevacizumab Sales by Type
5.3 Americas Bevacizumab Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bevacizumab Sales by Region
6.1.1 APAC Bevacizumab Sales by Region (2018-2023)
6.1.2 APAC Bevacizumab Revenue by Region (2018-2023)
6.2 APAC Bevacizumab Sales by Type
6.3 APAC Bevacizumab Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Bevacizumab by Country
7.1.1 Europe Bevacizumab Sales by Country (2018-2023)
7.1.2 Europe Bevacizumab Revenue by Country (2018-2023)
7.2 Europe Bevacizumab Sales by Type
7.3 Europe Bevacizumab Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Bevacizumab by Country
8.1.1 Middle East & Africa Bevacizumab Sales by Country (2018-2023)
8.1.2 Middle East & Africa Bevacizumab Revenue by Country (2018-2023)
8.2 Middle East & Africa Bevacizumab Sales by Type
8.3 Middle East & Africa Bevacizumab Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bevacizumab
10.3 Manufacturing Process Analysis of Bevacizumab
10.4 Industry Chain Structure of Bevacizumab
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bevacizumab Distributors
11.3 Bevacizumab Customer
12 WORLD FORECAST REVIEW FOR BEVACIZUMAB BY GEOGRAPHIC REGION
12.1 Global Bevacizumab Market Size Forecast by Region
12.1.1 Global Bevacizumab Forecast by Region (2024-2029)
12.1.2 Global Bevacizumab Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Bevacizumab Forecast by Type
12.7 Global Bevacizumab Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Genentech
13.1.1 Genentech Company Information
13.1.2 Genentech Bevacizumab Product Portfolios and Specifications
13.1.3 Genentech Bevacizumab Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Genentech Main Business Overview
13.1.5 Genentech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Bevacizumab Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Bevacizumab by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Bevacizumab by Country/Region, 2018, 2022 & 2029
2.2 Bevacizumab Segment by Type
2.2.1 Avastin (bevacizumab)
2.2.2 Mvasi (bevacizumab-awwb)
2.3 Bevacizumab Sales by Type
2.3.1 Global Bevacizumab Sales Market Share by Type (2018-2023)
2.3.2 Global Bevacizumab Revenue and Market Share by Type (2018-2023)
2.3.3 Global Bevacizumab Sale Price by Type (2018-2023)
2.4 Bevacizumab Segment by Application
2.4.1 Cancer
2.4.2 Eye Diease
2.5 Bevacizumab Sales by Application
2.5.1 Global Bevacizumab Sale Market Share by Application (2018-2023)
2.5.2 Global Bevacizumab Revenue and Market Share by Application (2018-2023)
2.5.3 Global Bevacizumab Sale Price by Application (2018-2023)
3 GLOBAL BEVACIZUMAB BY COMPANY
3.1 Global Bevacizumab Breakdown Data by Company
3.1.1 Global Bevacizumab Annual Sales by Company (2018-2023)
3.1.2 Global Bevacizumab Sales Market Share by Company (2018-2023)
3.2 Global Bevacizumab Annual Revenue by Company (2018-2023)
3.2.1 Global Bevacizumab Revenue by Company (2018-2023)
3.2.2 Global Bevacizumab Revenue Market Share by Company (2018-2023)
3.3 Global Bevacizumab Sale Price by Company
3.4 Key Manufacturers Bevacizumab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bevacizumab Product Location Distribution
3.4.2 Players Bevacizumab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BEVACIZUMAB BY GEOGRAPHIC REGION
4.1 World Historic Bevacizumab Market Size by Geographic Region (2018-2023)
4.1.1 Global Bevacizumab Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Bevacizumab Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Bevacizumab Market Size by Country/Region (2018-2023)
4.2.1 Global Bevacizumab Annual Sales by Country/Region (2018-2023)
4.2.2 Global Bevacizumab Annual Revenue by Country/Region (2018-2023)
4.3 Americas Bevacizumab Sales Growth
4.4 APAC Bevacizumab Sales Growth
4.5 Europe Bevacizumab Sales Growth
4.6 Middle East & Africa Bevacizumab Sales Growth
5 AMERICAS
5.1 Americas Bevacizumab Sales by Country
5.1.1 Americas Bevacizumab Sales by Country (2018-2023)
5.1.2 Americas Bevacizumab Revenue by Country (2018-2023)
5.2 Americas Bevacizumab Sales by Type
5.3 Americas Bevacizumab Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bevacizumab Sales by Region
6.1.1 APAC Bevacizumab Sales by Region (2018-2023)
6.1.2 APAC Bevacizumab Revenue by Region (2018-2023)
6.2 APAC Bevacizumab Sales by Type
6.3 APAC Bevacizumab Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Bevacizumab by Country
7.1.1 Europe Bevacizumab Sales by Country (2018-2023)
7.1.2 Europe Bevacizumab Revenue by Country (2018-2023)
7.2 Europe Bevacizumab Sales by Type
7.3 Europe Bevacizumab Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Bevacizumab by Country
8.1.1 Middle East & Africa Bevacizumab Sales by Country (2018-2023)
8.1.2 Middle East & Africa Bevacizumab Revenue by Country (2018-2023)
8.2 Middle East & Africa Bevacizumab Sales by Type
8.3 Middle East & Africa Bevacizumab Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bevacizumab
10.3 Manufacturing Process Analysis of Bevacizumab
10.4 Industry Chain Structure of Bevacizumab
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bevacizumab Distributors
11.3 Bevacizumab Customer
12 WORLD FORECAST REVIEW FOR BEVACIZUMAB BY GEOGRAPHIC REGION
12.1 Global Bevacizumab Market Size Forecast by Region
12.1.1 Global Bevacizumab Forecast by Region (2024-2029)
12.1.2 Global Bevacizumab Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Bevacizumab Forecast by Type
12.7 Global Bevacizumab Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Genentech
13.1.1 Genentech Company Information
13.1.2 Genentech Bevacizumab Product Portfolios and Specifications
13.1.3 Genentech Bevacizumab Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Genentech Main Business Overview
13.1.5 Genentech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Bevacizumab Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Bevacizumab Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Avastin (bevacizumab)
Table 4. Major Players of Mvasi (bevacizumab-awwb)
Table 5. Global Bevacizumab Sales by Type (2018-2023) & (K Units)
Table 6. Global Bevacizumab Sales Market Share by Type (2018-2023)
Table 7. Global Bevacizumab Revenue by Type (2018-2023) & ($ million)
Table 8. Global Bevacizumab Revenue Market Share by Type (2018-2023)
Table 9. Global Bevacizumab Sale Price by Type (2018-2023) & (USD/Unit)
Table 10. Global Bevacizumab Sales by Application (2018-2023) & (K Units)
Table 11. Global Bevacizumab Sales Market Share by Application (2018-2023)
Table 12. Global Bevacizumab Revenue by Application (2018-2023)
Table 13. Global Bevacizumab Revenue Market Share by Application (2018-2023)
Table 14. Global Bevacizumab Sale Price by Application (2018-2023) & (USD/Unit)
Table 15. Global Bevacizumab Sales by Company (2018-2023) & (K Units)
Table 16. Global Bevacizumab Sales Market Share by Company (2018-2023)
Table 17. Global Bevacizumab Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Bevacizumab Revenue Market Share by Company (2018-2023)
Table 19. Global Bevacizumab Sale Price by Company (2018-2023) & (USD/Unit)
Table 20. Key Manufacturers Bevacizumab Producing Area Distribution and Sales Area
Table 21. Players Bevacizumab Products Offered
Table 22. Bevacizumab Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Bevacizumab Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Bevacizumab Sales Market Share Geographic Region (2018-2023)
Table 27. Global Bevacizumab Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Bevacizumab Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Bevacizumab Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Bevacizumab Sales Market Share by Country/Region (2018-2023)
Table 31. Global Bevacizumab Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Bevacizumab Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Bevacizumab Sales by Country (2018-2023) & (K Units)
Table 34. Americas Bevacizumab Sales Market Share by Country (2018-2023)
Table 35. Americas Bevacizumab Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Bevacizumab Revenue Market Share by Country (2018-2023)
Table 37. Americas Bevacizumab Sales by Type (2018-2023) & (K Units)
Table 38. Americas Bevacizumab Sales by Application (2018-2023) & (K Units)
Table 39. APAC Bevacizumab Sales by Region (2018-2023) & (K Units)
Table 40. APAC Bevacizumab Sales Market Share by Region (2018-2023)
Table 41. APAC Bevacizumab Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Bevacizumab Revenue Market Share by Region (2018-2023)
Table 43. APAC Bevacizumab Sales by Type (2018-2023) & (K Units)
Table 44. APAC Bevacizumab Sales by Application (2018-2023) & (K Units)
Table 45. Europe Bevacizumab Sales by Country (2018-2023) & (K Units)
Table 46. Europe Bevacizumab Sales Market Share by Country (2018-2023)
Table 47. Europe Bevacizumab Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Bevacizumab Revenue Market Share by Country (2018-2023)
Table 49. Europe Bevacizumab Sales by Type (2018-2023) & (K Units)
Table 50. Europe Bevacizumab Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Bevacizumab Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Bevacizumab Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Bevacizumab Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Bevacizumab Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Bevacizumab Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Bevacizumab Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Bevacizumab
Table 58. Key Market Challenges & Risks of Bevacizumab
Table 59. Key Industry Trends of Bevacizumab
Table 60. Bevacizumab Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Bevacizumab Distributors List
Table 63. Bevacizumab Customer List
Table 64. Global Bevacizumab Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Bevacizumab Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Bevacizumab Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Bevacizumab Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Bevacizumab Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Bevacizumab Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Bevacizumab Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Bevacizumab Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Bevacizumab Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Bevacizumab Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Bevacizumab Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Bevacizumab Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Bevacizumab Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Bevacizumab Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Genentech Basic Information, Bevacizumab Manufacturing Base, Sales Area and Its Competitors
Table 79. Genentech Bevacizumab Product Portfolios and Specifications
Table 80. Genentech Bevacizumab Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 81. Genentech Main Business
Table 82. Genentech Latest Developments
Table 83. Amgen Basic Information, Bevacizumab Manufacturing Base, Sales Area and Its Competitors
Table 84. Amgen Bevacizumab Product Portfolios and Specifications
Table 85. Amgen Bevacizumab Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 86. Amgen Main Business
Table 87. Amgen Latest Developments
Table 1. Bevacizumab Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Bevacizumab Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Avastin (bevacizumab)
Table 4. Major Players of Mvasi (bevacizumab-awwb)
Table 5. Global Bevacizumab Sales by Type (2018-2023) & (K Units)
Table 6. Global Bevacizumab Sales Market Share by Type (2018-2023)
Table 7. Global Bevacizumab Revenue by Type (2018-2023) & ($ million)
Table 8. Global Bevacizumab Revenue Market Share by Type (2018-2023)
Table 9. Global Bevacizumab Sale Price by Type (2018-2023) & (USD/Unit)
Table 10. Global Bevacizumab Sales by Application (2018-2023) & (K Units)
Table 11. Global Bevacizumab Sales Market Share by Application (2018-2023)
Table 12. Global Bevacizumab Revenue by Application (2018-2023)
Table 13. Global Bevacizumab Revenue Market Share by Application (2018-2023)
Table 14. Global Bevacizumab Sale Price by Application (2018-2023) & (USD/Unit)
Table 15. Global Bevacizumab Sales by Company (2018-2023) & (K Units)
Table 16. Global Bevacizumab Sales Market Share by Company (2018-2023)
Table 17. Global Bevacizumab Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Bevacizumab Revenue Market Share by Company (2018-2023)
Table 19. Global Bevacizumab Sale Price by Company (2018-2023) & (USD/Unit)
Table 20. Key Manufacturers Bevacizumab Producing Area Distribution and Sales Area
Table 21. Players Bevacizumab Products Offered
Table 22. Bevacizumab Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Bevacizumab Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Bevacizumab Sales Market Share Geographic Region (2018-2023)
Table 27. Global Bevacizumab Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Bevacizumab Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Bevacizumab Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Bevacizumab Sales Market Share by Country/Region (2018-2023)
Table 31. Global Bevacizumab Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Bevacizumab Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Bevacizumab Sales by Country (2018-2023) & (K Units)
Table 34. Americas Bevacizumab Sales Market Share by Country (2018-2023)
Table 35. Americas Bevacizumab Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Bevacizumab Revenue Market Share by Country (2018-2023)
Table 37. Americas Bevacizumab Sales by Type (2018-2023) & (K Units)
Table 38. Americas Bevacizumab Sales by Application (2018-2023) & (K Units)
Table 39. APAC Bevacizumab Sales by Region (2018-2023) & (K Units)
Table 40. APAC Bevacizumab Sales Market Share by Region (2018-2023)
Table 41. APAC Bevacizumab Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Bevacizumab Revenue Market Share by Region (2018-2023)
Table 43. APAC Bevacizumab Sales by Type (2018-2023) & (K Units)
Table 44. APAC Bevacizumab Sales by Application (2018-2023) & (K Units)
Table 45. Europe Bevacizumab Sales by Country (2018-2023) & (K Units)
Table 46. Europe Bevacizumab Sales Market Share by Country (2018-2023)
Table 47. Europe Bevacizumab Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Bevacizumab Revenue Market Share by Country (2018-2023)
Table 49. Europe Bevacizumab Sales by Type (2018-2023) & (K Units)
Table 50. Europe Bevacizumab Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Bevacizumab Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Bevacizumab Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Bevacizumab Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Bevacizumab Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Bevacizumab Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Bevacizumab Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Bevacizumab
Table 58. Key Market Challenges & Risks of Bevacizumab
Table 59. Key Industry Trends of Bevacizumab
Table 60. Bevacizumab Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Bevacizumab Distributors List
Table 63. Bevacizumab Customer List
Table 64. Global Bevacizumab Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Bevacizumab Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Bevacizumab Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Bevacizumab Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Bevacizumab Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Bevacizumab Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Bevacizumab Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Bevacizumab Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Bevacizumab Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Bevacizumab Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Bevacizumab Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Bevacizumab Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Bevacizumab Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Bevacizumab Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Genentech Basic Information, Bevacizumab Manufacturing Base, Sales Area and Its Competitors
Table 79. Genentech Bevacizumab Product Portfolios and Specifications
Table 80. Genentech Bevacizumab Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 81. Genentech Main Business
Table 82. Genentech Latest Developments
Table 83. Amgen Basic Information, Bevacizumab Manufacturing Base, Sales Area and Its Competitors
Table 84. Amgen Bevacizumab Product Portfolios and Specifications
Table 85. Amgen Bevacizumab Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 86. Amgen Main Business
Table 87. Amgen Latest Developments
LIST OF FIGURES
Figure 1. Picture of Bevacizumab
Figure 2. Bevacizumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bevacizumab Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Bevacizumab Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Bevacizumab Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Avastin (bevacizumab)
Figure 10. Product Picture of Mvasi (bevacizumab-awwb)
Figure 11. Global Bevacizumab Sales Market Share by Type in 2022
Figure 12. Global Bevacizumab Revenue Market Share by Type (2018-2023)
Figure 13. Bevacizumab Consumed in Cancer
Figure 14. Global Bevacizumab Market: Cancer (2018-2023) & (K Units)
Figure 15. Bevacizumab Consumed in Eye Diease
Figure 16. Global Bevacizumab Market: Eye Diease (2018-2023) & (K Units)
Figure 17. Global Bevacizumab Sales Market Share by Application (2022)
Figure 18. Global Bevacizumab Revenue Market Share by Application in 2022
Figure 19. Bevacizumab Sales Market by Company in 2022 (K Units)
Figure 20. Global Bevacizumab Sales Market Share by Company in 2022
Figure 21. Bevacizumab Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Bevacizumab Revenue Market Share by Company in 2022
Figure 23. Global Bevacizumab Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Bevacizumab Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Bevacizumab Sales 2018-2023 (K Units)
Figure 26. Americas Bevacizumab Revenue 2018-2023 ($ Millions)
Figure 27. APAC Bevacizumab Sales 2018-2023 (K Units)
Figure 28. APAC Bevacizumab Revenue 2018-2023 ($ Millions)
Figure 29. Europe Bevacizumab Sales 2018-2023 (K Units)
Figure 30. Europe Bevacizumab Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Bevacizumab Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Bevacizumab Revenue 2018-2023 ($ Millions)
Figure 33. Americas Bevacizumab Sales Market Share by Country in 2022
Figure 34. Americas Bevacizumab Revenue Market Share by Country in 2022
Figure 35. Americas Bevacizumab Sales Market Share by Type (2018-2023)
Figure 36. Americas Bevacizumab Sales Market Share by Application (2018-2023)
Figure 37. United States Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Bevacizumab Sales Market Share by Region in 2022
Figure 42. APAC Bevacizumab Revenue Market Share by Regions in 2022
Figure 43. APAC Bevacizumab Sales Market Share by Type (2018-2023)
Figure 44. APAC Bevacizumab Sales Market Share by Application (2018-2023)
Figure 45. China Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Bevacizumab Sales Market Share by Country in 2022
Figure 53. Europe Bevacizumab Revenue Market Share by Country in 2022
Figure 54. Europe Bevacizumab Sales Market Share by Type (2018-2023)
Figure 55. Europe Bevacizumab Sales Market Share by Application (2018-2023)
Figure 56. Germany Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Bevacizumab Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Bevacizumab Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Bevacizumab Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Bevacizumab Sales Market Share by Application (2018-2023)
Figure 65. Egypt Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Bevacizumab in 2022
Figure 71. Manufacturing Process Analysis of Bevacizumab
Figure 72. Industry Chain Structure of Bevacizumab
Figure 73. Channels of Distribution
Figure 74. Global Bevacizumab Sales Market Forecast by Region (2024-2029)
Figure 75. Global Bevacizumab Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Bevacizumab Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Bevacizumab Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Bevacizumab Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Bevacizumab Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Bevacizumab
Figure 2. Bevacizumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bevacizumab Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Bevacizumab Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Bevacizumab Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Avastin (bevacizumab)
Figure 10. Product Picture of Mvasi (bevacizumab-awwb)
Figure 11. Global Bevacizumab Sales Market Share by Type in 2022
Figure 12. Global Bevacizumab Revenue Market Share by Type (2018-2023)
Figure 13. Bevacizumab Consumed in Cancer
Figure 14. Global Bevacizumab Market: Cancer (2018-2023) & (K Units)
Figure 15. Bevacizumab Consumed in Eye Diease
Figure 16. Global Bevacizumab Market: Eye Diease (2018-2023) & (K Units)
Figure 17. Global Bevacizumab Sales Market Share by Application (2022)
Figure 18. Global Bevacizumab Revenue Market Share by Application in 2022
Figure 19. Bevacizumab Sales Market by Company in 2022 (K Units)
Figure 20. Global Bevacizumab Sales Market Share by Company in 2022
Figure 21. Bevacizumab Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Bevacizumab Revenue Market Share by Company in 2022
Figure 23. Global Bevacizumab Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Bevacizumab Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Bevacizumab Sales 2018-2023 (K Units)
Figure 26. Americas Bevacizumab Revenue 2018-2023 ($ Millions)
Figure 27. APAC Bevacizumab Sales 2018-2023 (K Units)
Figure 28. APAC Bevacizumab Revenue 2018-2023 ($ Millions)
Figure 29. Europe Bevacizumab Sales 2018-2023 (K Units)
Figure 30. Europe Bevacizumab Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Bevacizumab Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Bevacizumab Revenue 2018-2023 ($ Millions)
Figure 33. Americas Bevacizumab Sales Market Share by Country in 2022
Figure 34. Americas Bevacizumab Revenue Market Share by Country in 2022
Figure 35. Americas Bevacizumab Sales Market Share by Type (2018-2023)
Figure 36. Americas Bevacizumab Sales Market Share by Application (2018-2023)
Figure 37. United States Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Bevacizumab Sales Market Share by Region in 2022
Figure 42. APAC Bevacizumab Revenue Market Share by Regions in 2022
Figure 43. APAC Bevacizumab Sales Market Share by Type (2018-2023)
Figure 44. APAC Bevacizumab Sales Market Share by Application (2018-2023)
Figure 45. China Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Bevacizumab Sales Market Share by Country in 2022
Figure 53. Europe Bevacizumab Revenue Market Share by Country in 2022
Figure 54. Europe Bevacizumab Sales Market Share by Type (2018-2023)
Figure 55. Europe Bevacizumab Sales Market Share by Application (2018-2023)
Figure 56. Germany Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Bevacizumab Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Bevacizumab Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Bevacizumab Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Bevacizumab Sales Market Share by Application (2018-2023)
Figure 65. Egypt Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Bevacizumab Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Bevacizumab in 2022
Figure 71. Manufacturing Process Analysis of Bevacizumab
Figure 72. Industry Chain Structure of Bevacizumab
Figure 73. Channels of Distribution
Figure 74. Global Bevacizumab Sales Market Forecast by Region (2024-2029)
Figure 75. Global Bevacizumab Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Bevacizumab Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Bevacizumab Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Bevacizumab Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Bevacizumab Revenue Market Share Forecast by Application (2024-2029)
